ROCKVILLE, Md., Aug. 7, 2019 /PRNewswire/ -- DrFirst announced today their collaboration to deliver single sign-on (SSO) access to HIPAA compliant messaging is now available. Using DrFirst Backline and Imprivata Mobile Device Access to enable fast, secure access to shared mobile devices and applications, users can now securely communicate in real-time across care te

- Presentation scheduled for 2:30 pm ET on August 14, 2019 - VANCOUVER, Aug. 7, 2019 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on advancing targeted therapeutics for the treatment of patients with significant unmet needs in hematology and on

Second quarter 2019 revenue of $131 million Second quarter 2019 net loss of $44 million Second quarter 2019 Adjusted EBITDA1 of $60 million Generated cash flow from operating activities of $97 million in the first six months of 2019 and concluded the quarter wi

NEWARK, Calif., Aug. 7, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported financial results for the second quarter ended June 30, 2019, and provided a corporate update. "We continue to make great progress in advancing our three clinical assets in diverse disease areas and are pleased with our cash runway

PDUFA Action Date is Dec. 22, 2019 LAVAL, Quebec, Aug. 7, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced that the U.S. Food and Drug Administration (FDA) has accepted th

LOS ANGELES, Aug. 7, 2019 /PRNewswire/ -- Cole Moscatel and his wife Kelsea Moscatel, creators of new luxury, lifestyle platform Snob World, recently d

CARLSBAD, Calif., Aug. 7, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported its financial results for the second quarter and year-to-date 2019 and recent business highlights.

WILMINGTON, Del. and REHOVOT, Israel, Aug. 7, 2019 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA), a leading pure-play agriculture company, and Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that Corteva will make an investment in Evogene's agriculture biologicals subs

WOONSOCKET, R.I., Aug. 7, 2019 /PRNewswire/ --Second Quarter Year-over-Year Highlights:Revenues increased 35.2% to $63.4 billion GAAP operating income increased to $3.3 billion Adjusted operating income (1) increased 55.1% to $4.0

WATFORD, England, Aug. 7, 2019 /PRNewswire/ -- Pilatus Comparator Solutions are delighted to announce further expansion of its global team with the appointment of Chad Finney to the position of Vice President North America. Chad brings with him a wealth of experience in Clinical Trials Supply and the wider health care market.